RankingsPricing
  1. JP-listed companies
  2. Daito Pharmaceutical Co., Ltd.
  3. Financials
  4. Total current assets

Daito Pharmaceutical Co., Ltd.【JP:4577】

Market cap
¥41B
P/E ratio
17.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
May 31, 202541,708+0.60%
May 31, 202441,460+1.96%
May 31, 202340,663+7.26%
May 31, 202237,909+16.90%
May 31, 202132,430+5.10%
May 31, 202030,855+26.66%
May 31, 201924,361-2.78%
May 31, 201825,056+2.92%
May 31, 201724,346+10.26%
May 31, 201622,081+1.68%
May 31, 201521,717

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)